Single Administration of p2TA (AB103), a CD28 Antagonist Peptide, Prevents Inflammatory and Thrombotic Reactions and Protects against Gastrointestinal Injury in Total-Body Irradiated Mice
The goal of this study was to elucidate the action of the CD28 mimetic peptide p2TA (AB103) that attenuates an excessive inflammatory response in mitigating radiation-induced inflammatory injuries. BALB/c and A/J mice were divided into four groups: Control (C), Peptide (P; 5 mg/kg of p2TA peptide),...
Main Authors: | Mirzoeva, Salida, Paunesku, Tatjana, Wanzer, M. Beau, Shirvan, Anat, Kaempfer, Raymond, Woloschak, Gayle E., Small, William |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108308/ |
Similar Items
-
AB103, a CD28 antagonist peptide: a new therapeutic agent in a model of severe sepsis
by: Teleman, D, et al.
Published: (2011) -
The Increase in Animal Mortality Risk following Exposure to Sparsely Ionizing Radiation Is Not Linear Quadratic with Dose
by: Haley, Benjamin M., et al.
Published: (2015) -
Nanoparticles for Applications in Cellular Imaging
by: Thurn, K Ted, et al.
Published: (2007) -
The Effects of Radiation and Dose-Fractionation on Cancer and Non-Tumor Disease Development
by: Liu, William, et al.
Published: (2012) -
Association between Thrombophilia and the Post-Thrombotic Syndrome
by: Rabinovich, Anat, et al.
Published: (2013)